[23, 24] This silencing of TFPI2 through promoter cytosine–phosphorothioate–guanine methylation has been widely reported to be associated with elevated cancer cell invasion and progression in many types of cancers including breast cancers and gliomas [25]. Here, TFPI2 is linked to glioma.